<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-254 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-254</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-254</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-12.html">extraction-schema-12</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of mechanisms, clinical findings, and evidence explaining the association between thymomas and autoimmunity.</div>
                <p><strong>Paper ID:</strong> paper-308d8504e83610df71690c0b8f4c1b629e03a3c5</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/308d8504e83610df71690c0b8f4c1b629e03a3c5" target="_blank">Thymoma and autoimmunity</a></p>
                <p><strong>Paper Venue:</strong> Cellular & Molecular Immunology</p>
                <p><strong>Paper TL;DR:</strong> The current scientific evidence detailing the various interactions between thymoma and autoimmune diseases, including myasthenia gravis, systemic lupus erythematosus, inappropriate antidiuretic hormone secretion, pure red cell aplasia, pernicious anemia, pemphigus and autoimmune thyroid diseases is compiled.</p>
                <p><strong>Cost:</strong> 0.014</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e254.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e254.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of mechanisms, clinical findings, and evidence explaining the association between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>MG</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Myasthenia gravis</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A humoral and cellular autoimmune disorder of the neuromuscular junction caused mainly by antibodies to the acetylcholine receptor (AChR), strongly associated with thymoma in many patients.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma and autoimmunity</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Myasthenia gravis (MG)</td>
                        </tr>
                        <tr>
                            <td><strong>prevalence_in_thymoma_patients</strong></td>
                            <td>Not explicitly reported for MG frequency among thymoma patients in this paper; paper reports that ~30% of thymoma patients have autoimmune conditions overall. Conversely, ~15% of MG patients have thymoma (paper reports thymoma in 15% of MG cases).</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Thymoma-derived defective thymic selection and export of autoreactive T cells (including CD4+/CD8+ double-positive/immature thymocytes), intrathymic germinal centers promoting autoantibody-producing B cells, and altered antigen presentation (HLA changes) that enable AChR autoimmunity.</td>
                        </tr>
                        <tr>
                            <td><strong>supporting_evidence</strong></td>
                            <td>Clinical and pathological observations described: presence of anti-AChR antibodies in MG patients; association of MG with WHO thymoma types B1/B2 that contain many CD4+/CD8+ double-positive thymocytes; intrathymic germinal centers in thymoma; reduction of anti-AChR antibody titers after thymectomy; Okumura et al. cohort (467 thymectomies) documenting strong thymoma–MG connection; histology showing immature thymocyte markers (TdT+, T6+, T4+, T8+), high Ki67 proliferation in thymomas (35–80%), and reduced mature CD4+ T cells.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td>The review notes heterogeneous outcomes after thymectomy: while thymectomy can reduce anti-AChR titers and improve disease, thymectomy has also been followed by appearance or exacerbation of other autoimmune diseases (e.g., SLE) in some cases, indicating that interventions altering thymic tissue can have complex effects.</td>
                        </tr>
                        <tr>
                            <td><strong>patient_demographics</strong></td>
                            <td>Okumura et al. cohort: majority female; no sex differences were documented between thymoma-associated MG and non-thymoma MG in that study; thymoma–MG association reported across a wide age range including infancy (case report).</td>
                        </tr>
                        <tr>
                            <td><strong>interventions_modulating_autoimmunity</strong></td>
                            <td>Thymectomy: reported to reduce anti-AChR antibody titers and can improve MG; pre-thymectomy anti-AChR levels may predict post-thymectomy MG risk (reported by Okumura et al.).</td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>Strong, repeatedly observed association between thymoma and MG supported by histology (immature thymocytes, germinal centers), immunology (anti-AChR antibodies), and clinical response to thymectomy; certain thymoma histotypes (B1/B2) enriched for immature double-positive thymocytes implicated in defective negative selection.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations</strong></td>
                            <td>Evidence is largely observational and correlative (case reports, cohort observations, histology); mechanistic causality is not definitively proven in experimental models within this review; heterogeneity of outcomes after thymectomy indicates incomplete understanding.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma and autoimmunity', 'publication_date_yy_mm': '2011-02'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e254.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e254.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of mechanisms, clinical findings, and evidence explaining the association between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Immature T-cell theory</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Immature T-cell (escape) theory</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A mechanistic hypothesis that thymoma contains/produces immature thymocytes that fail to undergo proper medullary negative selection and escape to the periphery as autoreactive T cells.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma and autoimmunity</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Thymoma-associated autoimmunity (general; e.g., MG, SLE, PRCA, pemphigus)</td>
                        </tr>
                        <tr>
                            <td><strong>prevalence_in_thymoma_patients</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Neoplastic thymic tissue recapitulates cortical architecture producing proliferating, immature thymocytes (TdT+, other immature markers) that bypass medullary selection (the 'escape' of medullary-tolerance step) and enter circulation as autoreactive T cells.</td>
                        </tr>
                        <tr>
                            <td><strong>supporting_evidence</strong></td>
                            <td>Histological/immunohistochemical findings: neoplastic cortical thymocytes express immature markers (TdT+, T6+, T4+, T8+); quantitative Ki67 staining shows high proliferation in thymomas (35–80%), similar to younger thymuses; thymomas (B1/B2) contain large numbers of CD4+/CD8+ double-positive T cells; observed reduction in mature CD4+ T cells in thymomas relative to normal thymus.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_demographics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>interventions_modulating_autoimmunity</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>Thymomas show histological and proliferative features of immature thymocyte populations and reduced mature T-cell representation, providing a plausible cellular substrate for escape of autoreactive T cells and consequent autoimmunity.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations</strong></td>
                            <td>Mechanism is inferential from histology and immunophenotyping; direct demonstration that these escaped immature thymocytes cause specific human autoimmune disease is not provided in this review.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma and autoimmunity', 'publication_date_yy_mm': '2011-02'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e254.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e254.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of mechanisms, clinical findings, and evidence explaining the association between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Neoplastic-genetic theory</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Neoplastic--genetic theory</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A hypothesis that thymoma-associated hyperproliferation increases genetic mutation risk in thymic epithelial/thymocyte populations, altering antigen presentation and selection and promoting autoreactivity.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma and autoimmunity</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Thymoma-associated autoimmunity (general; e.g., MG)</td>
                        </tr>
                        <tr>
                            <td><strong>prevalence_in_thymoma_patients</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>High proliferation in cortical thymocytes and genetic/phenotypic changes in neoplastic epithelial cells (e.g., reduced HLA-DR expression) lead to abnormal positive/negative selection and increased survival/export of self-reactive T cells; certain HLA types (HLA-A24, HLA-B8) may interact with this pathology to predispose to MG.</td>
                        </tr>
                        <tr>
                            <td><strong>supporting_evidence</strong></td>
                            <td>Observations reported: thymomas show increased cortical proliferation; thymocytes from proliferative cortical areas show self-reactivity (cited); neoplastic epithelial cells display slightly reduced HLA-DR expression compared with normal thymus; Machens et al. reported correlations between thymic pathology and HLA types associated with MG; thymocyte genetic instability suggested as theoretical risk.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_demographics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>interventions_modulating_autoimmunity</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>Genetic/phenotypic alterations in thymic epithelial cells and highly proliferative thymocytes in thymoma could perturb thymic selection thresholds and antigen presentation (HLA), providing a mechanistic link to autoimmunity.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations</strong></td>
                            <td>Direct genetic mutation-causality data are limited in this review; evidence is associative (HLA correlations and altered HLA-DR expression) rather than demonstrative of specific pathogenic mutations causing autoimmunity.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma and autoimmunity', 'publication_date_yy_mm': '2011-02'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e254.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e254.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of mechanisms, clinical findings, and evidence explaining the association between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Combined cellular-humoral theory</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Combined cellular and humoral deregulation theory</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A two-step model where thymoma-derived autoreactive T cells initiate cellular autoimmunity and subsequently enable activation of autoreactive B cells through aberrant CD4 T-cell help, producing pathogenic autoantibodies.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma and autoimmunity</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Thymoma-associated autoimmunity with autoantibody production (particularly myasthenia gravis, pemphigus, etc.)</td>
                        </tr>
                        <tr>
                            <td><strong>prevalence_in_thymoma_patients</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Step 1: export of autoreactive (often CD8-rich) T cells with impaired tolerance from thymoma. Step 2: activation/expansion of aberrant CD4 T cells that provide help to B cells, leading to production of disease-causing autoantibodies.</td>
                        </tr>
                        <tr>
                            <td><strong>supporting_evidence</strong></td>
                            <td>Presence of aberrant autoimmune CD4 T cells in thymoma-associated MG reported; detection of autoantibodies in thymoma-associated diseases; histologic intrathymic germinal centers (in thymoma) consistent with local B-cell activation; PRCA cases show lymphoid aggregation in bone marrow suggesting humoral/cellular interplay.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_demographics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>interventions_modulating_autoimmunity</strong></td>
                            <td>Thymectomy can reduce autoantibody titers (e.g., anti-AChR) supporting role of thymic source of autoantibody-promoting activity; however, thymectomy has variable downstream effects on systemic autoimmunity in some reports.</td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>A model integrating cellular autoreactivity (escaped T cells) with humoral responses (B-cell autoantibody production) explains coexistence of cell-mediated and antibody-mediated paraneoplastic phenomena in thymoma patients.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations</strong></td>
                            <td>Model synthesizes clinical, serologic and histologic observations but lacks direct mechanistic proof (e.g., tracing autoreactive T-cell clones from thymoma to peripheral B-cell activation) in the studies cited by this review.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma and autoimmunity', 'publication_date_yy_mm': '2011-02'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e254.4">
                <h3 class="extraction-instance">Extracted Data Instance 4 (e254.4)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of mechanisms, clinical findings, and evidence explaining the association between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Other autoimmune comorbidities</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Other autoimmune diseases reported with thymoma (clustered)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A broad set of autoimmune and paraneoplastic conditions reported in association with thymoma, including SLE, pure red cell aplasia, pemphigus variants, autoimmune thyroid disease and various cytopenias.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma and autoimmunity</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Systemic lupus erythematosus (SLE); acquired pure red cell aplasia (PRCA); pemphigus vulgaris / paraneoplastic pemphigus / bullous pemphigoid; pernicious anemia; autoimmune thyroid diseases (e.g., Graves'); polymyositis/myopathy; thrombocytopenia; neutropenia; autoimmune hemolytic anemia; dermatomyositis; rheumatoid arthritis; ulcerative colitis; scleroderma; Takayasu syndrome; cortical encephalitis; Sjögren's syndrome; SIADH (paraneoplastic/autoimmune link).</td>
                        </tr>
                        <tr>
                            <td><strong>prevalence_in_thymoma_patients</strong></td>
                            <td>Overall: ~30% of thymoma patients have autoimmune conditions (paper). Specific: SLE co-occurrence estimated 1.5–2% in clinical epidemiology studies and up to 10% in studies with thymus biopsy review; PRCA coexists with thymoma in ~5% of cases; up to 50% of thymoma patients with autoimmunity may have two autoimmune diseases concurrently (paper report).</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>General thymic dysregulation leading to impaired negative selection and generation/export of autoreactive T cells, possible altered antigen presentation and local intrathymic germinal center formation enabling B-cell autoantibody production; mechanisms likely overlap with the three theories above (immature T-cell escape, neoplastic-genetic changes, cellular-to-humoral conversion). SIADH has been linked to autoimmune mechanisms though specifics remain unclear.</td>
                        </tr>
                        <tr>
                            <td><strong>supporting_evidence</strong></td>
                            <td>Epidemiological associations and case reports/case series summarized: meta-analysis and multiple case reports of SLE–thymoma comorbidity; histology in PRCA showing small germinal centers and bone marrow lymphoid aggregation; case reports of remission of steroid-resistant SLE or bullous dermatoses after thymomectomy; reported autoantibodies in various thymoma-associated syndromes.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td>Some reports describe appearance or exacerbation of autoimmune disease (notably SLE) following thymectomy, indicating that thymoma resection does not uniformly prevent autoimmunity and may, in some cases, precede new autoimmune manifestations.</td>
                        </tr>
                        <tr>
                            <td><strong>patient_demographics</strong></td>
                            <td>Limited demographic detail across conditions; SLE–thymoma reports emphasize late-onset SLE should prompt consideration of thymoma; cohorts often report more females but data are heterogeneous; specific ages vary widely (including infancy for MG in isolated report).</td>
                        </tr>
                        <tr>
                            <td><strong>interventions_modulating_autoimmunity</strong></td>
                            <td>Thymectomy: reported to induce remission in some steroid-resistant SLE cases and regression of paraneoplastic pemphigus after thymoma resection; variable effects overall (some reports of post-thymectomy emergence of autoimmune disease).</td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>Thymoma is associated with a wide spectrum of autoimmune/paraneoplastic diseases beyond MG, with converging histological and serological evidence implicating disturbed thymic tolerance and local germinal-center activity as unifying contributors.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations</strong></td>
                            <td>Most evidence for non-MG associations is from case reports, small series, or retrospective reviews; prevalence estimates vary between studies; mechanistic detail is limited and heterogeneous across listed diseases.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma and autoimmunity', 'publication_date_yy_mm': '2011-02'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis <em>(Rating: 2)</em></li>
                <li>Immunohistochemical evidence of active thymocyte proliferation in thymoma. Its possible role in the pathogenesis of autoimmune diseases <em>(Rating: 2)</em></li>
                <li>Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease <em>(Rating: 2)</em></li>
                <li>Correlation of thymic pathology with HLA in myasthenia gravis <em>(Rating: 2)</em></li>
                <li>Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience <em>(Rating: 1)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>